Abstract
The management of electrical storm from ventricular tachycardia (VT-ES) in patients with structural heart disease and advanced heart failure (advanced HF) is challenging. In addition to refractory VT, the downstream sequelae of VT-ES in patients with advanced HF include further worsening of pump function and end-organ damage, often leading to early mortality.1–4 Catheter ablation is an important strategy in the management of drug-refractory VT-ES but carries a high risk of periprocedural morbidity and adverse outcomes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
